Tigecycline May Selectively Target Leukemic Stem Cells in CML [Leukemia]

Tigecycline inhibits mitochondrial oxidative phosphorylation to target leukemic stem cells (LSC).

from Cancer via ola Kala on Inoreader http://ift.tt/2z75gZI
via IFTTT